Phase 1 Idiopathic Inflammatory Myopathy (IIM) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)+1 more

Polina Stepensky60 enrolled1 locationNCT07085676

Recruiting

Phase 1

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)+1 more

Beijing GoBroad Hospital44 enrolled2 locationsNCT06980597